Harrow Health, Inc. 8.625% Senior Notes due 2026
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-6.76-4.17-1.66-2.839.26-76.00-51.95-12.83-28.77-14.96N/AN/A
Price/Sales ratio
41.256.831.591.263.273.853.633.184.572.80N/A3.85
Price/Book Value ratio
8.40-47.914.9512.985.477.106.5320.4814.875.16N/A7.10
Price/Cash Flow ratio
-9.70-5.95-2.84-3.85197.22207.38-161.4945.49237.7295.13N/A207.38
Price/Free Cash Flow ratio
-9.47-5.38-1.73-3.43-89.37-222.11-84.83-9.86-66.79-2.45N/A-89.37
Price/Earnings Growth ratio
-0.25-0.080.170.04-0.040.65-1.73-0.031.20-0.31N/A-0.04
Dividend Yield
N/AN/AN/AN/AN/AN/AN/A0.05%N/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
34.17%46.41%50.70%49.55%60.06%67.26%70.40%74.86%71.34%69.55%63.17%60.06%
Operating Profit Margin
-611.15%-152.55%-79.64%-45.42%-12.61%-0.98%-3.33%-0.39%-1.97%0.33%4.30%-12.61%
Pretax Profit Margin
-609.43%-163.63%-96.26%-48.25%35.35%-0.24%-6.98%-24.66%-15.81%-18.38%-34.40%-0.24%
Net Profit Margin
-609.43%-163.63%-95.71%-44.76%35.35%-5.06%-6.99%-24.84%-15.89%-18.74%-34.38%-5.06%
Effective Tax Rate
0.28%-6.77%0.57%7.23%-132.98%-1973.60%-0.11%-0.74%-0.53%-1.96%0.04%-132.98%
Return on Assets
-98.78%-112.51%-70.05%-50.11%29.57%-4.38%-5.94%-18.31%-8.97%-7.81%-24.18%-4.38%
Return On Equity
-124.14%1147.94%-296.75%-458.31%59.08%-9.35%-12.57%-159.55%-51.71%-34.49%-334.70%-9.35%
Return on Capital Employed
-116.87%-169.25%-91.58%-67.03%-13.89%-1.07%-3.49%-0.32%-1.26%0.16%3.43%-13.89%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A6.34N/A
Quick Ratio
5.560.831.301.132.602.723.345.805.992.605.802.60
Cash ratio
5.260.490.890.690.550.380.374.335.161.505.160.55
Days of Sales Outstanding
17.8731.5553.4622.1317.3214.3319.8822.7526.31102.2920.6017.32
Days of Inventory outstanding
124.4998.9968.3560.7840.5171.9399.9884.5094.05100.0658.5640.51
Operating Cycle
142.36130.55121.8182.9257.8486.26119.86107.26120.37202.3563.6457.84
Days of Payables Outstanding
262.85238.86131.35105109.71161.4591.98103.6892.60197.26123.29109.71
Cash Conversion Cycle
-120.48-108.31-9.54-22.07-51.86-75.1927.883.5727.775.09-88.25-75.19
Debt Ratios
Debt Ratio
0.000.600.450.610.300.240.290.730.660.580.820.30
Debt Equity Ratio
0.00-6.221.925.580.610.520.626.373.852.584.710.61
Long-term Debt to Capitalization
N/A1.190.550.840.320.300.310.860.790.720.800.32
Total Debt to Capitalization
0.001.190.650.840.380.340.380.860.790.720.800.38
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A1.20N/A
Cash Flow to Debt Ratio
-292.61-1.29-0.90-0.600.040.06-0.060.070.010.020.060.04
Company Equity Multiplier
1.25-10.204.239.141.992.132.118.715.764.415.701.99
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-4.24-1.14-0.56-0.320.010.01-0.020.070.010.020.060.01
Free Cash Flow / Operating Cash Flow Ratio
1.021.101.631.12-2.20-0.931.90-4.61-3.55-38.720.56-2.20
Cash Flow Coverage Ratio
-292.61-1.29-0.90-0.600.040.06-0.060.070.010.020.060.04
Short Term Coverage Ratio
-292.61-530.61-2.53-14.720.210.39-0.2418.152.35N/A10.410.21
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/A-0.70%N/AN/AN/AN/A